BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1261 related articles for article (PubMed ID: 36424614)

  • 1. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.
    Lian X; Liu B; Wang C; Wang S; Zhuang Y; Li X
    Front Endocrinol (Lausanne); 2023; 14():1182776. PubMed ID: 37342266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
    Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
    Front Oncol; 2021; 11():711020. PubMed ID: 34621670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.
    Zheng M; Hu Y; Liu O; Li S; Wang Y; Li X; Liu J; Yang Q; Li X; Lin B
    Oxid Med Cell Longev; 2023; 2023():1261039. PubMed ID: 36743693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
    Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
    Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq.
    Liu X; Li J; Wang Q; Bai L; Xing J; Hu X; Li S; Li Q
    Front Immunol; 2022; 13():1012303. PubMed ID: 36311759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
    Mi K; Zeng L; Chen Y; Yang S
    Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
    Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
    Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
    Shen L; Li A; Cui J; Liu H; Zhang S
    J Ovarian Res; 2024 Apr; 17(1):82. PubMed ID: 38627854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of monocyte-related prognosis model based on comprehensive analysis of bulk RNA-seq and single-cell RNA-seq in high-grade serous ovarian cancer.
    Xu Y; Tan S; Huang W; Wang YX
    Medicine (Baltimore); 2023 Dec; 102(50):e36548. PubMed ID: 38115318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients.
    Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z
    Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
    Shu J; Jiang J; Zhao G
    Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer.
    Zhang Y; Dong K; Jia X; Du S; Wang D; Wang L; Qu H; Zhu S; Wang Y; Wang Z; Zhang S; Sun W; Fu S
    BMC Med Genomics; 2023 Jun; 16(1):140. PubMed ID: 37337170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer.
    Wang Z; Zhang J; Dai F; Li B; Cheng Y
    J Ovarian Res; 2023 Jan; 16(1):12. PubMed ID: 36642706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
    Chai R; Zhao Y; Su Z; Liang W
    Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.